Page 81 - GTM-2-3

Global Translational Medicine Thromboembolism risk in non-small-cell lung cancer

16. Key NS, Khorana AA, Kuderer NM, et al., 2020, Venous https://doi.org/10.1024/0301-1526/a000359
thromboembolism prophylaxis and treatment in patients 27. Tagalakis V, Levi D, Agulnik JS, et al., 2007, High risk of deep
with cancer: ASCO clinical practice guideline update. J Clin vein thrombosis in patients with non-small cell lung cancer:
Oncol, 38: 496–520.
A cohort study of 493 patients. J Thorac Oncol, 2: 729–734.
https://doi.org/10.1200/JCO.19.01461 https://doi.org/10.1097/JTO.0b013e31811ea275
17. Rami-Porta R, Bolejack V, Giroux DJ, et al., 2014, The IASLC 28. Hicks LK, Cheung MC, Ding K, et al., 2009, Venous
lung cancer staging project: The new database to inform the thromboembolism and nonsmall cell lung cancer: A pooled
eighth edition of the TNM classification of lung cancer. analysis of National Cancer Institute of Canada Clinical
J Thorac Oncol, 9: 1618–1624. Trials Group trials. Cancer, 115: 5516–5525.
https://doi.org/10.1097/JTO.0000000000000334 https://doi.org/10.1002/cncr.24596
18. Varki A, 2007, Trousseau’s syndrome: Multiple definitions 29. Wang J, Hu B, Li T, et al., 2019, The EGFR-rearranged
and multiple mechanisms. Blood, 110: 1723–1729. adenocarcinoma is associated with a high rate of venous
https://doi.org/10.1182/blood-2006-10-053736 thromboembolism. Ann Transl Med, 7: 724.
19. Sawada M, Miyake S, Ohdama S, et al., 1999, Expression https://doi.org/10.21037/atm.2019.12.24
of tissue factor in non-small-cell lung cancers and its 30. Dearden S, Stevens J, Wu YL, et al., 2013, Mutation
relationship to metastasis. Br J Cancer, 79: 472–477. incidence and coincidence in non small-cell lung cancer:
https://doi.org/10.1038/sj.bjc.6690073 Meta-analyses by ethnicity and histology (mutMap). Ann
Oncol, 24: 2371–2376.
20. Goldin-Lang P, Tran QV, Fichtner I, 2008, Tissue factor
expression pattern in human non-small cell lung cancer https://doi.org/10.1093/annonc/mdt205
tissues indicate increased blood thrombogenicity and tumor 31. Qian X, Fu M, Zheng J, et al., 2021, Driver genes associated
metastasis. Oncol Rep, 20: 123–128. with the incidence of venous thromboembolism in patients
https://doi.org/10.3892/or.20.1.123 with non-small-Cell lung cancer: A systematic review and
meta-analysis. Front Oncol, 11: 680191.
21. Minamiya Y, Matsuzaki I, Sageshima M, et al., 2004,
Expression of tissue factor mRNA and invasion of blood https://doi.org/10.3389/fonc.2021.680191
vessels by tumor cells in non-small cell lung cancer. Surg 32. Lee YG, Kim I, Lee E, et al., 2014, Risk factors and
Today, 34: 1–5. prognostic impact of venous thromboembolism in Asian
https://doi.org/10.1007/s00595-003-2643-y patients with non-small cell lung cancer. Thromb Haemost,
111: 1112–1120.
22. Belting M, Ahamed J, Ruf W, 2005, Signaling of the tissue
factor coagulation pathway in angiogenesis and cancer. https://doi.org/10.1160/TH13-11-0956
Arterioscler Thromb Vasc Biol, 25: 1545–1550. 33. Shaw AT, Kim DW, Mehra R, et al., 2014, Ceritinib in
https://doi.org/10.1161/01.atv.0000171155.05809.bf ALK-rearranged non-small-cell lung cancer. N Engl J Med,
370: 1189–1197.
23. Sato T, Tsujino I, Ikeda D, et al., 2006, Trousseau’s syndrome
associated with tissue factor produced by pulmonary https://doi.org/10.1056/NEJMoa1311107
adenocarcinoma. Thorax, 61: 1009–1010. 34. Ou SH, Ahn JS, De Petris L, et al., 2016, Alectinib in
https://doi.org/10.1136/thx.2004.031492 crizotinib-refractory ALK-rearranged non-small-cell lung
cancer: A phase II global study. J Clin Oncol, 34: 661–668.
24. Rong Y, Belozerov VE, Tucker-Burden C, et al., 2009,
Epidermal growth factor receptor and PTEN modulate https://doi.org/10.1200/jco.2015.63.9443
tissue factor expression in glioblastoma through JunD/ 35. Carrier M, Khorana AA, Zwicker JI, et al., 2012, Venous
activator protein-1 transcriptional activity. Cancer Res, thromboembolism in cancer clinical trials: Recommendation
69: 2540–2549. for standardized reporting and analysis. J Thromb Haemost,
https://doi.org/10.1158/0008-5472.CAN-08-1547 10: 2599–2601.
25. Magnus N, Garnier D, Rak J, 2010, Oncogenic epidermal https://doi.org/10.1111/jth.12028
growth factor receptor up-regulates multiple elements of 36. Alexander M, Kirsa S, Wolfe R, et al., 2014, Thromboembolism
the tissue factor signaling pathway in human glioma cells. in lung cancer-an area of urgent unmet need. Lung Cancer,
Blood, 116: 815–818. 84: 275–280.
https://doi.org/10.1182/blood-2009-10-250639 https://doi.org/10.1016/j.lungcan.2014.02.009
26. Gary T, 2014, Cancer related venous thromboembolism- 37. Chew HK, Davies AM, Wun T, et al., 2008, The incidence
prophylaxis and therapy. Vasa, 43: 245–251. of venous thromboembolism among patients with primary

Volume 2 Issue 3 (2023) 8 https://doi.org/10.36922/gtm.1027